Table 3.

Price Responsiveness of Pre-Gap Statin Compliance (PDC ≥80%) by Quarter

Time Period	Marginal Effect (SE)
	Enrollees with Gap Coverage	Enrollees without Gap Coverage
Effective price ($)
1st quarter	0.033 (0.142)	−0.408 (0.166)**
2nd quarter	−0.325 (0.214)	−0.910 (0.226)***
3rd quarter	−0.101 (0.220)***	−1.088 (0.234)***
4th quarter	−0.857 (0.236)***	−0.996 (0.261)***
Predicted probability of hitting the gap
1st quarter	−0.007 (0.051)	−0.261 (0.081)***
2nd quarter	−0.268 (0.068)***	−0.559 (0.106)***
3rd quarter	−0.583 (0.069)***	−0.762 (0.108)***
4th quarter	−0.459 (0.075)***	−0.513 (0.117)***

Corrected for sample-selectivity associated with choosing gap coverage.

^**p < .05

^***p < .01.

PDC, proportion of days covered.